Lipophilic antioxidants in patients with phenylketonuria
Open Access
- 1 January 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 77 (1) , 185-188
- https://doi.org/10.1093/ajcn/77.1.185
Abstract
Background: Low serum ubiquinone-10 concentrations have been described in phenylketonuric patients fed natural-protein-restricted diets. Such low concentrations may be related to increased free radical damage. Objective: We evaluated the relation between low serum ubiquinone-10 concentrations and other lipophilic antioxidants (tocopherol and retinol), selenium, glutathione peroxidase activity, and malondialdehyde concentrations as a marker of lipid peroxidation. Design: This was a cross-sectional study of 58 patients with phenylketonuria (aged 2–36 y; median: 13 y) under dietary treatment, 58 age-matched control subjects, and 30 children with moderate hyperphenylalaninemia fed unrestricted diets (aged 3–17 y; median: 7.5 y). Serum ubiquinone-10 concentrations were analyzed by HPLC with electrochemical detection. Serum retinol, serum tocopherol, and plasma malondialdehyde were analyzed by HPLC with ultraviolet detection. Results: A significant positive correlation was observed between ubiquinone-10 and tocopherol (r = 0.510, P < 0.001) in the patients with phenylketonuria. After the patients were stratified into 2 groups according to ubiquinone-10 values, significantly lower concentrations of tocopherol were observed in group 1 (low ubiquinone values) than in group 2 (normal ubiquinone values), the hyperphenylalaninemic children, and the control group. Plasma malondialdehyde concentrations were significantly higher in group 1 than in the other groups. No significant differences between groups 1 and 2 were observed in daily intakes of selenium, ascorbate, tocopherol, or retinol. Conclusions: Plasma lipid peroxidation seems to be increased in phenylketonuria. Low concentrations of ubiquinone-10 could be associated with either excessive tocopherol consumption or high malondialdehyde concentrations in patients with phenylketonuria.Keywords
This publication has 20 references indexed in Scilit:
- Plasma phenylalanine is asociated with decreased serum ubiquine‐10 concentrations in phenylketonuriaJournal of Inherited Metabolic Disease, 2001
- Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patientsThe American Journal of Clinical Nutrition, 2000
- Nutrition, physical growth, and bone density in treated phenylketonuriaEuropean Journal of Pediatrics, 2000
- Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse?Journal of Neuroscience Research, 2000
- Decreased serum ubiquinone-10 concentrations in phenylketonuriaThe American Journal of Clinical Nutrition, 1999
- Plasma micronutrient concentrations in infants undergoing therapy for phenylketonuriaBiological Trace Element Research, 1999
- Antioxidant status in hyperphenylalaninemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 1998
- Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementationClinica Chimica Acta; International Journal of Clinical Chemistry, 1992
- Serum selenium levels in individuals on PKU dietsJournal of Inherited Metabolic Disease, 1991
- Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemiaNeurochemical Research, 1988